Research-use context: This article is provided for laboratory research and educational purposes only. It is not medical, therapeutic, diagnostic, veterinary, dosing or human-use guidance.
Why one method is rarely the whole story
HPLC and mass spectrometry are frequently mentioned together in peptide documentation because they answer different analytical questions. HPLC separates components under defined chromatographic conditions and can be used to estimate relative purity. Mass spectrometry measures mass-to-charge information that can support molecular identity.
Purity does not prove identity
A chromatogram can show a dominant peak without establishing, by itself, that the peak is the intended peptide. Conversely, a molecular mass consistent with the target does not quantify every impurity. Combining complementary methods creates a stronger analytical picture.
Quantity is separate
Neither a headline HPLC purity percentage nor an identity result should automatically be read as confirmation of the amount of peptide in a vial. Quantitative testing requires an appropriate method and should be reported as a distinct result.
Make the report auditable
Useful documentation identifies the batch, laboratory, test date and method. Raw or supporting analytical data can add context where available. VOREVIA’s quality framework is built around this separation of identity, purity, quantity and traceability.